Phase 1b Dose-finding Study of Venetoclax With Ibrutinib and Rituximab in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

Detalles Bibliográficos
Autores principales: Petrillo, Alessandra, Ip, Andrew, Della Pia, Alexandra, Gill, Sarvainder, Zenreich, Joshua, Gutierrez, Martin, McNeill, Ann, Feldman, Tatyana, Leslie, Lori A., Goy, Andre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208873/
https://www.ncbi.nlm.nih.gov/pubmed/35747844
http://dx.doi.org/10.1097/HS9.0000000000000719

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208873/
https://www.ncbi.nlm.nih.gov/pubmed/35747844
http://dx.doi.org/10.1097/HS9.0000000000000719

Ejemplares similares